Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Bioequivalence in Netherlands
Total 2 results
Actelion
Completed
Study in Healthy Male Subjects to Demonstrate Bioequivalence of 1600 μg Selexipag Administered as Eight Tablets of 200 μg or as Single Tablet of 1600 μg
Bioequivalence
Netherlands
Maastricht University Medical Center
Completed
Bio-equivalence Study
Bioavailability | Bioequivalence
Netherlands
Sponsors and Collaborators
Principal Investigator Mohanad Omar Ahmed, Msc Pharmacy Practice Department- Horus University
Mª Victoria Maestre Sanchez
ASST Cremona, Cremona
Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd.
Everett Meyer
Hospital ASEPEYO Sant Cugat
Korean Society of Spine Surgery
Jiande Branch, Second Affiliated Hospital, School of Medicine, Zhejiang University
GFI
Neurophth Therapeutics Inc
Apollo Neuroscience, Inc.
Hospital Durand, Argentina
Alma Lasers Inc.
Agency for Science, Technology and Research
iCAD
Aptis Medical
Kupfer, David J., M.D.
Eurofins Genoma
RMIT University, Melbourne, Australia
Nacuity Pharmaceuticals, Inc.
View Full List
Medical Conditions
Fever
Major Liver Surgery
Recurrent Clear Cell Sarcoma of Soft Tissue
RISS Stage III Plasma Cell Myeloma
T-LGL Leukemia
Treatment Decisions
The Strength Properties of the Aorta in Vitro
Scleredema
Dienogest
Gastric Cancer Stage IIIB-IIIC
Chronic Constipation Symptoms
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
24 Hours Esophageal PH and Multichannel Intraluminal Impedance Testing
Corneal Cross-Linking
Immune-Mediated Inflammatory Disease
Luteal Phase Support
Rheumatoid Arthritis(RA)
Metachronous Adenoma
Splenic Trauma
Disorder of Fluid Balance
View Full List
Drug Interventions
Olopatadine
TPN-101
Desvenlafaxine
Oxycodone/acetaminophen 5/325 mg
MLN2480
Capecitabine/cisplatin
Standard of care (SOC) for COVID-19
OnabotulinumtoxinA
Anticholinergic
Intravenous deferiprone
Camptosar
Fospropofol disodium, propofol
PD-1/PD-L1 inhibitor
Capecitabine and IMRT (if randomized to this arm)
THC
Intravenous Formulation of PD-0332991
Letrozole
Midazolam
GLPG1837 multiple ascending doses
RDX227675
View Full List
CROs by country
Contract Research Organizations in Azerbaijan
Contract Research Organizations in Cambodia
Contract Research Organizations in Colombia
Contract Research Organizations in Equatorial Guinea
Contract Research Organizations in Finland
Contract Research Organizations in France
Contract Research Organizations in Georgia
Contract Research Organizations in Greece
Contract Research Organizations in Mexico
Contract Research Organizations in Nigeria
Contract Research Organizations in Romania
Contract Research Organizations in Slovenia
Contract Research Organizations in Togo
CRO list by country
CROs in Switzerland
PRA Health Sciences
NDA Regulatory Science (NDA Group)
Medidee
Cepha
Axon
eResearchTechnology, Inc (ERT)
Caidya
MD Biosciences
OPIS
Rede Optimus Hopitalar AG
All CROs in Switzerland
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe